search
Back to results

Effects of Backward Gait Training With Exoskeleton on Motor Functions

Primary Purpose

Gait, Hemiplegic, Physical Therapy

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Gait training with EksoNR
Backward gait training with EksoNR
Sponsored by
Alvernia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gait, Hemiplegic focused on measuring Robotic exoskeleton, Backward gait training, Forward gait training

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years of age or older
  • English or Spanish speaking
  • A diagnosis first stroke (intracerebral hemorrhage or acute ischemic stroke)
  • Referred to Reading Rehabilitation Hospital Outpatient Physical Therapy Clinic (hereafter referred to as outpatient PT)

Exclusion Criteria:

  • Unable to follow 1-step commands
  • > 220 pounds (100 kg)
  • Height < 5'0" or > 6'4"
  • Unable to take a few steps with assistance
  • A score of > 42/56 on Berg Balance Scale (BBS)
  • Prior use of any exoskeleton
  • Severe cardiac disease (New York Heart Association Classification IV)
  • Severe spasticity (Modified Ashworth score > 3)
  • Unstable spine or unhealed pelvic/limb fractures
  • Active heterotrophic ossification impacting lower extremity range of motion
  • Significant lower or upper extremity contractures
  • Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion
  • Psychiatric or cognitive issues that could interfere with operating the exoskeleton
  • Pregnancy
  • Colostomy
  • Poor skin integrity in areas in contact with the EksoNRTM
  • Unresolved deep vein thrombosis
  • Lower limb prosthesis or amputation
  • Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs
  • ROM restrictions preventing normal, reciprocal gait
  • Inability to stand for > 60 seconds due to pain or orthostatic hypotension

Sites / Locations

  • Sunnyview Rehabilitation Hospital
  • Reading Hospital Rehabilitation at WyomissingRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard Care with Ekso Group

Standard Care with Ekso and Backward Walking Group

Arm Description

Participants in the SCG (n=31) will attend two 45-minute treatment sessions per week for a minimum of 8 and a maximum of 10 total sessions. For each participant, an individualized plan of care consistent with evidence-based practice standards will be provided based on rehabilitation goals. The interventions during each treatment session will include forward gait training with EksoNR, neuromuscular movement-related tasks, mobility tasks, and interventions using products and technology, and education for caregivers, family, and friends.

Participants in the SCBWG (n=31) will attend two 45-minute treatment sessions per week for a minimum of 8 and a maximum of 10 total sessions. Once a week, each participant will receive standard care as described in the standard care with Ekso group.Once a week, each participant will receive backward walking training with EksoNR during their treatment session.

Outcomes

Primary Outcome Measures

Changes in backward gait speed
Changes from baseline backward gait speed measured by 3-Meter Backwards Walk Test at post-intervention
Changes in forward gait speed
Changes from baseline forward gait speed measured by 6-Minute Walk Test at post-intervention
Changes in Functional Ambulation Category
Changes from baseline ambulation ability at post-intervention. Functional Ambulation Category ranges from 0-5, and a higher score indicates a better outcome (greater independence in ambulation).
Changes in Berg Balance Scale
Changes from baseline static balance and fall risk at post-intervention. Berg Balance Scale ranges from 0 to 56, and a higher score indicates a better outcome (better balance and lower fall risk).
Changes in Patient Health Questionnaire-9
Changes from baseline depressive symptoms at post-intervention. Patient Health Questionnaire-9 ranges from 0 to 27, and a higher score indicates a worse outcome (greater depressive symptoms).
Changes in reciprocal activities in antagonistic muscles measured by Electromyography
Changes from baseline neuromuscular control of leg muscles at post-intervention. A greater reciprocity between leg antagonistic muscles indicate a better outcome.

Secondary Outcome Measures

Full Information

First Posted
November 1, 2021
Last Updated
May 10, 2023
Sponsor
Alvernia University
Collaborators
The Reading Hospital and Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05133362
Brief Title
Effects of Backward Gait Training With Exoskeleton on Motor Functions
Official Title
Investigating Effects of Backward Gait Training With Exoskeleton on Gait Function, Balance and Depression Following Stroke and the Impact of Social Determinants of Health and Depression on Patients' Adherence to Physical Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 25, 2022 (Actual)
Primary Completion Date
December 25, 2023 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Alvernia University
Collaborators
The Reading Hospital and Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The proposed study aims to optimize patient outcomes and treatment intervention using a robotic exoskeleton in adults with cerebrovascular accidents (CVA, stroke) by investigating the following: AIM 1 is to investigate the effect of backward gait training with exoskeleton on motor function. AIM 2 is to investigate the effect of backward gait training with exoskeleton on depression. AIM 3 is to investigate the impact of social determinants of health and depression on patient adherence to physical therapy.
Detailed Description
Based on previous findings on backward gait training as well as the use of a wearable robotic exoskeleton in forward gait training, we hypothesize that backward gait training using exoskeleton leads to greater improvements in functional mobility, neuromuscular control and balance (AIM 1) and depression (AIM 2) in patients with stroke, when compared to standard of care, which includes forward gait training using exoskeleton. Findings from AIM 1 and 2 will provide novel evidence on the effects of backward gait training with exoskeleton in people with stroke and serve as a foundation for optimizing physical therapy protocols to improve motor functions and mental health. AIM 3 investigates the impact of social determinants of health and depression on patient adherence to physical therapy. Patient adherence (also called compliance) refers to the degree to which patients follow treatment recommendations prescribed by their health care provider.34 Even though patient adherence leads to positive treatment outcomes,35,36 it is affected by many factors, including patients' understanding of their disease and associated treatment (i.e., health literacy), social support, and depression.36-38 This experimental study employs a repeated measures design with participants randomly assigned to either a Standard Care with Ekso Group (SCG; control group, n=31) or a Standard Care with Ekso and Backward Walking Group (SCBWG; experimental group, n=31) in AIMs 1 and 2. AIMs 1 and 2 will be achieved using the group assignment as independent variables and motor function and depression as dependent variables. AIM 3 will be achieved using social determinants of health and depression as independent variables and patient adherence to physical therapy as an independent variable.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gait, Hemiplegic, Physical Therapy
Keywords
Robotic exoskeleton, Backward gait training, Forward gait training

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
62 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard Care with Ekso Group
Arm Type
Active Comparator
Arm Description
Participants in the SCG (n=31) will attend two 45-minute treatment sessions per week for a minimum of 8 and a maximum of 10 total sessions. For each participant, an individualized plan of care consistent with evidence-based practice standards will be provided based on rehabilitation goals. The interventions during each treatment session will include forward gait training with EksoNR, neuromuscular movement-related tasks, mobility tasks, and interventions using products and technology, and education for caregivers, family, and friends.
Arm Title
Standard Care with Ekso and Backward Walking Group
Arm Type
Experimental
Arm Description
Participants in the SCBWG (n=31) will attend two 45-minute treatment sessions per week for a minimum of 8 and a maximum of 10 total sessions. Once a week, each participant will receive standard care as described in the standard care with Ekso group.Once a week, each participant will receive backward walking training with EksoNR during their treatment session.
Intervention Type
Device
Intervention Name(s)
Gait training with EksoNR
Intervention Description
Participants will receive forward gait training with EksoNR
Intervention Type
Procedure
Intervention Name(s)
Backward gait training with EksoNR
Intervention Description
Participants will receive backward gait training with EksoNR
Primary Outcome Measure Information:
Title
Changes in backward gait speed
Description
Changes from baseline backward gait speed measured by 3-Meter Backwards Walk Test at post-intervention
Time Frame
Baseline and within 1 week after the intervention
Title
Changes in forward gait speed
Description
Changes from baseline forward gait speed measured by 6-Minute Walk Test at post-intervention
Time Frame
Baseline and within 1 week after the intervention
Title
Changes in Functional Ambulation Category
Description
Changes from baseline ambulation ability at post-intervention. Functional Ambulation Category ranges from 0-5, and a higher score indicates a better outcome (greater independence in ambulation).
Time Frame
Baseline and within 1 week after the intervention
Title
Changes in Berg Balance Scale
Description
Changes from baseline static balance and fall risk at post-intervention. Berg Balance Scale ranges from 0 to 56, and a higher score indicates a better outcome (better balance and lower fall risk).
Time Frame
Baseline and within 1 week after the intervention
Title
Changes in Patient Health Questionnaire-9
Description
Changes from baseline depressive symptoms at post-intervention. Patient Health Questionnaire-9 ranges from 0 to 27, and a higher score indicates a worse outcome (greater depressive symptoms).
Time Frame
Baseline and within 1 week after the intervention
Title
Changes in reciprocal activities in antagonistic muscles measured by Electromyography
Description
Changes from baseline neuromuscular control of leg muscles at post-intervention. A greater reciprocity between leg antagonistic muscles indicate a better outcome.
Time Frame
Baseline and within 1 week after the intervention
Other Pre-specified Outcome Measures:
Title
Adherence to physical therapy
Description
Adherence to physical therapy is defined as ≥ 80% attendance to weekly physical therapy as recorded in the Data Collection Sheet. Based on the definition, patient adherence will be considered a dichotomous variable (yes/no) and will be used to test the association between health literacy and patient adherence.
Time Frame
During the intervention
Title
Level of health literacy
Description
Level of health literacy is measured by Newest Vital Sign. The Newest Vital Sign is a 6-question screening tool that identifies participants' risk of low or limited health literacy (HL) based on interpreting an ice cream nutrition label, available from Pfizer Pharmaceutical Company. The score ranges 0-6. A score of 0-1 suggests a high likelihood of limited literacy, a score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always indicates adequate literacy.
Time Frame
Baseline
Title
Perceived Social Support
Description
Level of perceived social support is measured by Multidimensional Scale of Perceived Social Support. It is a self-administered scale, and the score ranges from 12 to 84. A score of 12-35 suggests a low perceived social support, a score of 36-60 suggests a medium social support, and a score of 61-84 suggests a high social support.
Time Frame
Baseline
Title
Educational attainment
Description
Each participant's answer regarding their educational level in the Demographics Questionnaire will be classified into one of the two categories: individuals who completed some college education and individuals whose highest educational attainment was high school or less. This dichotomous variable will be used to determine if the level of educational attainment is associated with adherence to physical therapy.
Time Frame
Baseline
Title
Language spoken at home
Description
Each participant's answer regarding the language spoken at home in the Demographics Questionnaire will be classified into one of the two categories: individuals who speak English at home and individuals who speak other languages than English at home. This dichotomous variable will be used to determine if linguistic proficiency is associated with adherence to physical therapy.
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years of age or older English or Spanish speaking A diagnosis first stroke (intracerebral hemorrhage or acute ischemic stroke) Referred to Reading Rehabilitation Hospital Outpatient Physical Therapy Clinic (hereafter referred to as outpatient PT) Exclusion Criteria: Unable to follow 1-step commands > 220 pounds (100 kg) Height < 5'0" or > 6'4" Unable to take a few steps with assistance A score of > 42/56 on Berg Balance Scale (BBS) Severe cardiac disease (New York Heart Association Classification IV) Severe spasticity (Modified Ashworth score > 3) Unstable spine or unhealed pelvic/limb fractures Active heterotrophic ossification impacting lower extremity range of motion Significant lower or upper extremity contractures Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion Psychiatric or cognitive issues that could interfere with operating the exoskeleton Pregnancy Colostomy Poor skin integrity in areas in contact with the EksoNRTM Unresolved deep vein thrombosis Lower limb prosthesis or amputation Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs ROM restrictions preventing normal, reciprocal gait Inability to stand for > 60 seconds due to pain or orthostatic hypotension
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Soo Yeon Sun, PhD
Phone
6107968398
Email
soo.sun@alvernia.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Soo Yeon Sun
Organizational Affiliation
Alvernia University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sunnyview Rehabilitation Hospital
City
Schenectady
State/Province
New York
ZIP/Postal Code
12308
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amy Teale, PhD
Email
amy.teale@sphp.com
First Name & Middle Initial & Last Name & Degree
Melanie Melewski, DPT
Facility Name
Reading Hospital Rehabilitation at Wyomissing
City
Reading
State/Province
Pennsylvania
ZIP/Postal Code
19610
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karen Keenan

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Backward Gait Training With Exoskeleton on Motor Functions

We'll reach out to this number within 24 hrs